5 Growth Stocks for an AI Market in Transition

Listen to the audio version of this article (generated by AI).

On Nov. 5, a software company delivered the kind of earnings report you might expect from an AI boom.

Revenue climbed 31%. Cloud revenue jumped 60%. The number of customers generating more than $1 million in annual recurring revenue increased 58%.

That company was JFrog (FROG). And its results offer a clue about where investors can find growth while the AI data center trade struggles.

JFrog manages and secures the software packages companies build and deploy. As AI produces more software, businesses have more software to organize, protect, and deliver.

That creates demand even when a data center project gets pushed back.

Remember, you can be right about the technology and still own stocks whose earnings expectations need to come down.

You can also miss opportunities because you treat every AI company as the same investment.

That is the central idea behind our latest episode of Being Exponential. We examine five stocks with growth drivers that depend less directly on the next round of hyperscaler construction spending. And keep reading for another opportunity I am researching: the publicly traded companies that could help power Elon Musk’s push into payments and financial services.

Give it a watch here:

Playing Defense Doesn’t Mean Giving Up on Growth

The problem with the data center trade starts with expectations.

Demand for AI remains strong. But demand alone cannot secure a permit, lower financing costs, or deliver equipment caught in a supply shortage.

Washington, Wall Street, and supply chains all influence how quickly the largest cloud companies can build. My expectation is that those constraints produce a smaller spending increase than investors anticipate, followed by a period of elevated but steadier spending.

That can be painful for suppliers.

Suppose a company builds its earnings forecast around customers increasing spending every year. If those customers instead hold spending roughly flat, the supplier might still have a large business. But its expected growth changes.

Analysts lower earnings estimates. Investors reconsider the valuation. The stock adjusts.

That is why I believe the AI data center trade is transitioning — and why I am looking elsewhere for opportunities while that transition plays out.

The Best Cybersecurity Stocks to Buy

One of my strongest recommendations in cybersecurity is Cloudflare (NET).

Think of Cloudflare as a doorman for the websites using its network. It helps manage incoming traffic and distinguish legitimate visitors from unwanted activity.

Now introduce AI agents.

A person might visit a handful of websites while researching a purchase. Software agents can perform those tasks repeatedly, at machine speed. Website operators need controls over which agents enter and what they can access. Cloudflare already offers tools for setting those policies.

My thesis is that growing agent activity makes those controls more valuable.

In the episode, we also examine Cloudflare’s rebound around its 200-day moving average, a measure of its longer-term price trend. A recovery at that level becomes more interesting when an earnings report supports it.

The caveat is valuation. Cloudflare carries a substantial premium, so execution matters. A strong business can still deliver a disappointing stock return if investors pay too much.

JFrog offers another way to participate in AI adoption.

AI can accelerate software development. Companies still need to store the resulting software packages, check them for vulnerabilities, and track which versions reach customers.

More production creates more responsibility.

JFrog’s earnings show growing demand for that work. Beyond its revenue growth, the company reported net dollar retention of 124%. That measure tracks spending from existing customers, including expansion and contraction, and indicates that its customer relationships are growing in value.

I recommend this type of exposure because its business depends more directly on software activity than on the construction schedule for another server campus.

It is not immune to tighter technology budgets. But its customers have a different reason to spend.

The Best Health Care Stocks to Buy

Health care provides another set of opportunities.

Adaptive Biotechnologies (ADPT) develops clonoSEQ, a test used to detect and monitor small amounts of residual disease in certain blood cancers. The company delivered 39,587 tests in the third quarter, up 46% from a year earlier.

But how much further can that testing expand?

I see room for broader adoption and, with it, operating leverage. That means revenue can grow faster than operating expenses as a company spreads its existing costs across more business.

A laboratory does not necessarily need to double every expense to process substantially more tests.

That creates the possibility of faster profit growth as volume increases. Execution, reimbursement, and clinical adoption determine how much of that opportunity becomes reality.

Tempus AI (TEM) approaches health care through diagnostics, patient data, and AI tools that support more personalized treatment decisions.

The company reported third-quarter revenue growth of 23%. Adjusted earnings before interest, taxes, depreciation, and amortization rose to $25.6 million from $1.5 million a year earlier. That adjusted measure is distinct from net income, but the improvement illustrates the operating leverage we are watching.

The appeal is straightforward: More useful data and broader adoption can support a larger business without requiring expenses to rise at the same pace.

Tempus remains volatile. In the podcast, we examine its chart alongside its financial outlook because I want evidence that both the business and investor demand are improving.

Finally, consider Eli Lilly (LLY).

The debate around weight-loss drugs often centers on when growth slows. I think investors can underestimate how a more convenient treatment expands the potential customer base.

Lilly’s Foundayo, an oral weight-loss drug, received FDA approval in April. A pill gives eligible patients another treatment option, including those reluctant to use injections.

My thesis is that oral treatments extend the growth runway beyond what a saturation-focused outlook assumes.

That does not eliminate competition, coverage challenges, or treatment discontinuation. It does create another avenue for growth that has little direct connection to hyperscaler spending.

Stay Patient Without Standing Still

Over the next three to six months, I believe these five companies offer compelling alternatives while AI infrastructure stocks work through changing expectations.

Over three to five years, I still see substantial potential in the data center trade once earnings forecasts and valuations settle.

A disciplined growth investor can hold both views.

Demand for AI can keep growing while financing costs, Washington, and supply shortages slow construction. That is why we are waiting for spending expectations and the charts to provide a stronger foundation before getting aggressive with AI infrastructure.

But patience in one part of the market leaves plenty of room for research elsewhere.

The five companies we discussed today illustrate that approach: Find businesses with strong growth drivers that depend less directly on the next data center project. Another opportunity worth studying involves something you do every day — sending money, making purchases, and managing your finances.

That is the focus of my research into Elon Musk’s ambitions for payments and financial services.

Bringing those activities together requires technology and financial infrastructure. The companies supplying those capabilities could gain business if his plans take shape.

For you, the investment question is which publicly traded companies could benefit — and what would turn that possibility into revenue.

I have been studying those potential beneficiaries and the roles they could play. It is a separate investment thesis from the AI data center buildout, giving us another area to investigate while that trade stabilizes.

Watch my briefing to discover the companies I’m watching behind Musk’s financial ambitions, and why they could matter to your next investment decision.


Article printed from InvestorPlace Media, https://investorplace.com/hypergrowthinvesting/2026/11/5-growth-stocks-for-an-ai-market-in-transition/.

©2026 InvestorPlace Media, LLC